GHK-Cu Dosage Guide: Injectable and Topical Protocols

GHK-Cu modulates over 4,000 human genes, spanning collagen production, inflammatory response, antioxidant defense, and nerve repair. Roughly 60 published studies cover skin remodeling, wound healing, hair growth, and neuroprotection. Yet no official GHK-Cu dosage guideline exists. Not from the FDA, not from any medical board, not from any physician organization with prescribing authority.

So where do the numbers come from? A mix of plasma research, animal studies, a handful of dermatology trials, and a growing library of YouTube experiments from people documenting months of personal use with blood work and progress photos. The dosage ranges you see repeated across the internet converge on a surprisingly narrow band, which is either reassuring or a sign everyone is copying from the same source.

This guide pulls from published research, clinical data, and real-world reports to give you actionable protocols for both injectable and topical GHK-Cu. We cover dosage tiers, cycling schedules, goal-specific protocols, and the practical details of reconstitution and injection. For our full breakdown of GHK-Cu vendors and product quality, see our GHK-Cu comparison page.

Why GHK-Cu Dosing Isn't Straightforward

Your body already makes GHK-Cu. That is the first thing that separates it from most research peptides. Plasma levels sit around 200 ng/mL in your twenties, then drop roughly 60% by age 60 (down to about 80 ng/mL). To put those numbers in context: 200 ng/mL is the concentration at which GHK-Cu actively drives wound healing and collagen remodeling in cell culture studies. The peptide was first isolated from human plasma in 1973 by Dr. Loren Pickart, and the supplementation rationale is simple: replace what your body stopped making enough of.

The problem is that “replacement” does not come with a prescription insert. GHK-Cu has no FDA approval for any indication. Injectable GHK-Cu was classified FDA Category 2 in September 2023, which restricts 503A pharmacy compounding for injectable forms. In practice, this means your local compounding pharmacy cannot fill a GHK-Cu injection prescription the way it fills BPC-157 or other Category 1 peptides. 503B outsourcing facilities operate under different rules and may still produce it, but access varies by state. Topical formulations remain Category 1, meaning compounding pharmacies can still prepare them freely.

Two delivery routes serve fundamentally different purposes. Topical GHK-Cu delivers a localized signal to skin and hair follicles. Injectable GHK-Cu enters systemic circulation and reaches internal tissues, joints, and organs. The dose, the frequency, the cycling, and the expected timeline all differ between them.

This regulatory gap is exactly why community protocol data matters. When no governing body publishes dosing guidelines, the evidence base becomes a patchwork of clinical fragments, physician experience, and documented self-experiments. That patchwork is imperfect, but it is all anyone has to work with. We weigh all three sources throughout this guide, but we label which is which so you can calibrate your confidence accordingly.

Injectable GHK-Cu Dosage Ranges

The standard injectable GHK-Cu dosage converges across published sources, physician recommendations, and community protocols on the same range. That consistency is the closest thing to consensus you will find.

Dosage Tiers

All doses are subcutaneous injection, once daily, fixed dose. GHK-Cu is not weight-based. A 130 lb woman and a 220 lb man use the same 1 mg standard dose across nearly every protocol we reviewed.

Higher doses (3–4 mg) appear in scattered community reports. They do not show proportionally better results and carry increased copper exposure. More is not more with this peptide.

Reconstitution Math

Getting from a lyophilized vial to an accurate dose requires basic math. Common vial sizes and their concentrations:

A practical note on injection volume: most users find anything above 0.5 mL uncomfortable for a single subcutaneous site. If your dose math puts you above that threshold, split across two sites or add more BAC water to increase total vial volume while keeping the dose the same.

Frequency Options

Three frequency patterns appear consistently:

• Daily. Once per day for the duration of the cycle. Most common in clinical contexts.
• 5 on / 2 off. Five consecutive days of injection, two days rest. Popular in community protocols for managing copper exposure.
• 3x per week. Monday/Wednesday/Friday or similar spacing. Often used for maintenance phases.

Most community protocols recommend morning injection on an empty stomach, though no clinical data supports a specific time of day over another. Consistency matters more than timing.

Dilute your reconstituted GHK-Cu with extra bacteriostatic water beyond the standard ratio. The burning sensation at the injection site comes from copper ion concentration. More water means lower concentration per unit volume, which reduces the sting without changing the dose.

One more thing new users need to hear: reconstituted GHK-Cu has a blue or blue-green tint. This is normal. Copper(II) ions cause the color. If your solution is colorless, that is actually the quality concern, not the other way around.

Topical GHK-Cu Dosage Protocols

Topical GHK-Cu has something its injectable counterpart does not: multiple human clinical trials. The evidence base for rubbing it on your skin is stronger than the evidence base for injecting it, a fact most dosage guides gloss over.

Concentration Guide

Application is straightforward. Apply once or twice daily to clean skin. A pea-sized amount covers the full face; for scalp treatment, use a dropper to apply directly to thinning areas. Allow 10–15 minutes for absorption before layering other products. No cycling is needed for topical use. The localized copper exposure from a serum is negligible compared to systemic injection, so continuous use is the standard approach.

What to Avoid Layering

GHK-Cu topicals do not play well with certain actives. L-ascorbic acid (vitamin C in its pure form) can destabilize the copper-peptide bond. Same goes for AHAs and BHAs. Community reports suggest reduced efficacy when these are layered together. Separate them by several hours or alternate days.

Ascorbyl glucoside and other vitamin C derivatives are generally considered safe to use in the same routine since they do not create the same pH conflict.

The Contrarian MD View

Dr. Michael (Drmichaelsays), a physician with a growing following in the peptide space, argues that topical GHK-Cu is sufficient for most people seeking skin and hair benefits. His position: topical delivers the repair signal exactly where it is needed without systemic copper exposure. He warns about the rise of home-injecting cases in 2026 and questions whether the risk is justified for cosmetic goals.

This is a minority view among peptide practitioners, but it is a medically credentialed one worth considering.

Microneedling Combo

Microneedling followed by topical GHK-Cu application combines mechanical collagen induction with peptide signaling. The micro-channels created by needling allow deeper penetration into the dermal layer. This approach has limited formal study but is gaining traction among dermatologists who already use microneedling.

Cycling Protocols: Loading, Maintenance, and Time Off

The most common mistake with GHK-Cu is quitting after one cycle with minimal visible results. This is a collagen-remodeling peptide. Collagen turnover takes months. Expecting transformation in four weeks is setting yourself up for disappointment.

Injectable Cycling Table

Why cycle injectable but not topical? Two reasons. First, systemic copper accumulation is a real concern with daily injections over months. The off period lets your body clear excess copper. Second, receptor sensitivity. Continuous high-dose signaling can lead to receptor downregulation. Topical concentrations are too low and too localized to trigger either issue.

The Nick Trigili 12-Month Experiment

This is the longest documented personal GHK-Cu experiment on YouTube (85K views, former IFBB Pro bodybuilder). Trigili ran three complete cycles over 12 months and his findings challenge the typical narrative.

Cycle 1 produced minimal visible change. Cycles 2 and 3 delivered systemic results he did not expect: anti-inflammatory benefits, joint improvement, and recovery effects that went beyond the cosmetic benefits everyone markets GHK-Cu for. His conclusion: the peptide is “marketed wrong.” The systemic healing benefits may be more significant than the skin glow.

His recommended approach: plan for multiple cycles from the start. Budget the time and the peptide supply accordingly. Do not evaluate GHK-Cu based on a single 4-week run.

Copper Monitoring

If you are running injectable GHK-Cu, track serum copper and ceruloplasmin levels through standard blood work. Normal serum copper runs 70–140 mcg/dL. Ceruloplasmin, the protein that carries 95% of blood copper, should sit between 20–35 mg/dL. Values above these ranges after a cycle signal you need a longer off period.

Dr. Michael coined the term “Copper Uglies” for what happens when copper levels climb too high: collagen breakdown. The exact opposite of what you are trying to achieve.

Baseline blood work before your first cycle gives you a reference point. Draw again during the final week of each cycle, and once more two weeks into the off period to confirm levels are normalizing.

GHK-Cu Dosage by Goal: Skin, Hair, Healing, and Beyond

The right GHK-Cu dosage depends on what you are trying to accomplish. These protocols are compiled from clinical data, physician recommendations, and documented community experience.

1. Skin Rejuvenation

Protocol: 1 mg/day subcutaneous for 4–8 weeks, combined with topical 1–2% serum applied twice daily.

GHK-Cu stimulates production of collagen types I and III, plus decorin, elastin, and glycosaminoglycans. That is comprehensive extracellular matrix remodeling, not just a single collagen boost. Fine lines typically show improvement at the 4–8 week mark. Topical can continue indefinitely after the injectable cycle ends.

2. Hair Growth

Protocol: Topical 1–2% applied to scalp daily, plus injectable 1 mg/day subcutaneous for 8–12 weeks.

A 2025 open-label study reported 35% terminal hair growth with GHK-Cu microemulsion combined with minoxidil, compared to 18% with minoxidil alone. The GHK-Cu group entered anagen (growth phase) at 6 days versus 9 days for minoxidil only.

Set realistic timelines. Reduced shedding is typically the first sign, appearing at 4–8 weeks. New visible growth takes 8–16 weeks. Optimal results come at 6+ months, which means committing to multiple injectable cycles.

3. Wound Healing and Post-Surgical Recovery

Protocol: 1–2 mg/day subcutaneous for 2–4 weeks. Stack with BPC-157 for complementary mechanisms (see Stacking section). Apply topical GHK-Cu after granulation tissue has formed, not on open wounds.

GHK-Cu attracts immune cells and promotes angiogenesis (new blood vessel formation). In animal models, collagen deposition at wound sites increased measurably within 5 days of GHK-Cu treatment. This accelerates repair beyond what collagen synthesis alone provides.

4. Systemic Anti-Inflammatory

Protocol: 1–2 mg/day subcutaneous for 4–8 weeks.

This is the use case Nick Trigili considers the real value of GHK-Cu. After multiple cycles, he reports systemic benefits that overshadow the cosmetic effects. Joint comfort, recovery speed, and general inflammation markers all improved in his documented experience. Plan for 2–3 cycles minimum.

5. Cognitive and Neuroprotection

Protocol: 1 mg/day subcutaneous, standard cycling.

Thomas DeLauer (3.99M subscribers, 282K views on his GHK-Cu video) highlights the cognitive angle that most coverage skips. GHK-Cu's gene modulation includes pathways involved in reducing oxidative damage to neural tissue. This is the least clinically validated use case but one of the most intriguing based on the gene expression data.

Dr. Jones, DC, outlines an integrated stack for covering multiple goals simultaneously: injectable GHK-Cu plus oral collagen, vitamin C supplementation, and topical copper peptide serum.

What YouTube Experimenters Actually Report

Clinical protocols tell you what to take. YouTube experimenters tell you what actually happens when real people inject or apply GHK-Cu for weeks and months, then film the results.

We reviewed seven in-depth GHK-Cu videos. The five most informative:

Nick Trigili (12 months, 3 cycles, 85K views)

Former IFBB Pro bodybuilder who ran the longest documented GHK-Cu experiment on YouTube. Cycle 1 was underwhelming. Cycles 2 and 3 delivered systemic anti-inflammatory and healing results he did not anticipate. His key takeaway: GHK-Cu is “marketed wrong” as a beauty peptide when the systemic effects may be more significant.

William Day (8 weeks, 37K views)

No sponsorship, no product placement. His 8-week experiment provides an honest baseline for what early-stage GHK-Cu use looks like. He documents specific dosing, hair and skin observations, and adverse effects. This is what a normal person experiences, not an influencer curating content.

Thomas DeLauer (282K views, 3.99M subscribers)

The largest channel to cover GHK-Cu in depth. DeLauer's unique contribution is the cognitive and angiogenesis angles that virtually no blog post addresses. He cites 10 scientific references from PubMed, ScienceDirect, and JCI. His coverage of oxidative damage reduction in neural tissue opens a discussion most GHK-Cu content ignores entirely.

Quinn Stillson MD (89K views, 54 minutes)

The most medically rigorous GHK-Cu video available. A board-certified anti-aging physician who dedicates 21 chapters to the topic over 54 minutes. Stillson explicitly marks which claims have human data, which have animal data, and which are theoretical. He covers the cardiovascular angle (fibrinogen reduction), AHK-Cu versus GHK-Cu for hair, and devotes two full chapters to the cancer question. Dosing starts at 46:36.

Dr. Michael / Drmichaelsays (43K views)

The contrarian. A medical doctor who argues most people do not need to inject GHK-Cu. His position: topical application delivers the repair signal where it is needed for skin and hair without the copper toxicity risk. He warns about “Copper Uglies” and the rise of home-injecting without medical oversight.

Common Threads Across All Five

Skin glow tends to appear first (4–8 weeks). Hair improvement is the slowest (months, not weeks). Injection site burning is universal and manageable with dilution. Multiple cycles outperform single cycles by a wide margin.

An honest caveat: these are all n=1 experiments with inherent selection bias. People who get good results are more likely to make videos. The value is not in any single report but in the patterns that emerge independently across unrelated experimenters.

How to Reconstitute and Inject GHK-Cu

Reconstitution takes about five minutes once you have done it before. The first time takes ten.

Supplies

• GHK-Cu lyophilized powder vial
• Bacteriostatic water (BAC water)
• Alcohol swabs
• Insulin syringes (29–31 gauge, 1 mL)
• Sharps container

Reconstitution Steps

1. Swab the rubber stoppers on both the GHK-Cu vial and BAC water vial with alcohol. Let air-dry for 10–15 seconds.
2. Draw your chosen volume of BAC water (e.g., 2 mL for a 5 mg vial = 2.5 mg/mL concentration).
3. Insert the needle into the GHK-Cu vial. Angle it so the water runs down the inside glass wall. Never squirt directly onto the powder.
4. Let the vial sit for 1–2 minutes. Then gently swirl or roll between your palms. Never shake.
5. The solution will have a blue or blue-green tint. This is normal. Copper(II) ions cause the color. A colorless solution is the actual red flag.
6. Label the vial with the reconstitution date and concentration. Refrigerate at 2–8 degrees Celsius.
7. Use within 28–30 days. Do not freeze reconstituted peptides.

Injection Steps

1. Draw your dose from the reconstituted vial (e.g., 40 units for 1 mg from a 2.5 mg/mL solution).
2. Select an injection site: abdomen (2–3 inches from the navel) or front of the thigh.
3. Clean the site with an alcohol pad. Let it air-dry completely.
4. Pinch a skin fold. Insert the needle at a 45-degree angle.
5. Depress the plunger slowly. Wait 5–10 seconds before withdrawing.
6. Rotate injection sites daily. Left abdomen, right abdomen, left thigh, right thigh.

For the burning sensation: add extra BAC water during reconstitution to create a more dilute solution. You will draw a larger volume per dose, but the lower copper concentration per unit reduces the sting noticeably.

Storage Rules

Reconstituted GHK-Cu stays stable refrigerated for 28–30 days. Unreconstituted lyophilized powder can be stored at room temperature but lasts longer refrigerated or frozen. Never freeze the reconstituted solution. Keep vials upright and away from light.

Stacking GHK-Cu with Other Peptides

GHK-Cu is rarely used alone. Most protocols pair it with at least one other peptide for complementary effects.

Stack 1: GHK-Cu + BPC-157

This is the most popular GHK-Cu stack, and for good reason. The mechanisms are complementary rather than redundant. GHK-Cu drives collagen synthesis and extracellular matrix remodeling. BPC-157 promotes angiogenesis and growth factor expression. Together, they address tissue repair from two different angles.

Typical protocol: run both at standard doses (GHK-Cu 1 mg/day, BPC-157 250–500 mcg/day) in separate syringes during the same cycle window. They can be injected at the same time of day but should not be mixed in the same syringe. Some users split them AM/PM, though no evidence supports one timing over the other.

Stack 2: GHK-Cu + Thymosin Alpha-1

For users targeting immune function alongside tissue repair. Thymosin Alpha-1 modulates immune response while GHK-Cu handles the structural rebuilding. This stack appears in protocols focused on post-illness recovery or chronic inflammatory conditions. Typical Thymosin Alpha-1 dosing runs 1.6 mg subcutaneous 2–3x per week alongside standard GHK-Cu cycling.

Pre-Mixed Blends

Compounding pharmacies offer pre-mixed peptide blends. GLOW and KLOW are two common formulations that combine BPC-157, TB-500, GHK-Cu, and KPV in a single vial. These simplify the injection routine but remove your ability to adjust individual peptide doses.

The Dr. Jones Approach

Dr. Jones, DC, outlines an integrated daily protocol: injectable GHK-Cu combined with oral collagen supplementation, vitamin C (oral, not topical at the same time as GHK-Cu), and a topical copper peptide serum. The injectable signals your body to build collagen, oral collagen provides raw materials, and vitamin C serves as a cofactor in collagen synthesis.

For vendor quality comparisons on GHK-Cu and stacking peptides, check our vendor directory and grading methodology.

Safety, Side Effects, and Who Should Skip GHK-Cu

GHK-Cu has a better safety profile than most research peptides. But “better than most” comes with caveats.

Common Side Effects (Transient)

• Injection site burning or stinging (most reported, manageable with dilution)
• Redness or slight swelling at the injection site
• Mild nausea in the first few days (uncommon, typically resolves)
• Temporary skin flushing

These are almost universally transient. They tend to diminish after the first week.

Copper Toxicity

This is the real risk with injectable GHK-Cu over extended periods. Excess copper does not just fail to help. It actively breaks down collagen, a phenomenon Dr. Michael calls the “Copper Uglies.” Monitor serum copper and ceruloplasmin through blood work before, during, and after injectable cycles.

Signs of elevated copper: fatigue, nausea, abdominal pain, jaundice in severe cases. Cycling protocols exist specifically to manage this risk. Do not skip the off periods.

The Cancer Question

GHK-Cu promotes angiogenesis (new blood vessel formation), which could support tumor growth by supplying tumors with blood. At the same time, GHK-Cu modulates gene expression in ways that include anti-cancer pathways.

Quinn Stillson MD devotes two full chapters of his 54-minute deep dive to this nuance. His position: active cancer is a hard contraindication. History of cancer warrants a conversation with your oncologist. No one has definitively resolved which effect dominates clinically.

Hard Contraindications

• Active cancer or tumors
• Wilson's disease or copper metabolism disorders
• Pregnancy or breastfeeding
• Known copper allergy

Injectable vs. Topical Grade

Never inject a topical copper peptide serum. Topical products contain preservatives, emulsifiers, and excipients unsafe for injection. Injectable-grade GHK-Cu is lyophilized powder reconstituted with bacteriostatic water only. For guidance on verifying peptide quality, see our COA verification guide and peptide purity deep dive.

Regulatory Status

Injectable GHK-Cu is FDA Category 2 as of September 2023, restricting 503A compounding. Topical remains Category 1 and is widely available as an OTC cosmetic ingredient.

Frequently Asked Questions

What is the standard GHK-Cu dosage for injection?

1 mg subcutaneous once daily. Conservative users start at 0.5 mg. Aggressive protocols use 2 mg. Doses above 2 mg show no proportionally better results and increase copper exposure unnecessarily.

Is the blue-green color in reconstituted GHK-Cu normal?

Yes. The tint comes from copper(II) ions bound to the GHK tripeptide and confirms proper copper binding. A colorless solution may indicate inadequate copper content or a quality issue.

Should I inject GHK-Cu or use topical?

That depends on your goal. Topical has stronger human clinical evidence and suits localized skin and hair benefits. Injectable is preferred for systemic effects like healing, anti-inflammatory action, and tissue repair beyond the skin surface.

How long until I see results from GHK-Cu?

Topical skin improvements: 4–8 weeks. Injectable skin effects: 4–8 weeks per cycle. Hair growth: 8–16 weeks minimum, with optimal results at 6+ months. Systemic anti-inflammatory effects: may require 2–3 full cycles (4–8 months).

Can I stack GHK-Cu with BPC-157?

Yes, and it is the most popular GHK-Cu stack. The two peptides work through complementary mechanisms. Use separate syringes, same cycle timing.

Do I need to cycle injectable GHK-Cu?

Yes. Standard cycling is 4–8 weeks on, 4 weeks off. Extended cycles run 8–12 weeks on, 4 weeks off. The off period manages copper accumulation and maintains receptor sensitivity. Topical GHK-Cu does not require cycling.

Can I use topical GHK-Cu with vitamin C?

Avoid applying L-ascorbic acid at the same time as topical GHK-Cu. The acidic environment can destabilize the copper-peptide bond. Separate by several hours, alternate days, or switch to a derivative like ascorbyl glucoside.

Is GHK-Cu safe for someone with a cancer history?

Active cancer is a hard contraindication due to GHK-Cu's angiogenic properties. For cancer history in remission, GHK-Cu modulates both pro-angiogenic and anti-cancer gene pathways. Discuss with your oncologist before starting any protocol.